BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hernandez-rocha C, Vande Casteele N. JAK inhibitors: current position in treatment strategies for use in inflammatory bowel disease. Current Opinion in Pharmacology 2020;55:99-109. [DOI: 10.1016/j.coph.2020.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hernandez-Rocha C, Vande Casteele N. Corrigendum to 'JAK inhibitors: Current position in treatment strategies for use in inflammatory bowel disease'. Curr Opin Pharmacol 2021;58:68. [PMID: 33932913 DOI: 10.1016/j.coph.2021.03.009] [Reference Citation Analysis]
2 Spiewak TA, Patel A. User's Guide to JAK Inhibitors in Inflammatory Bowel Disease. Current Research in Pharmacology and Drug Discovery 2022. [DOI: 10.1016/j.crphar.2022.100096] [Reference Citation Analysis]
3 Saltović E, Mijandrušić-sinčić B, Braut A, Škrobonja I, Sever E, Glažar I, Pezelj-ribarić S, Muhvić-urek M. Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α4β7 Therapy. Dentistry Journal 2022;10:32. [DOI: 10.3390/dj10030032] [Reference Citation Analysis]